VEGFC and myocardial infarction: Given that VEGFC has immunomodulatory functions that extend beyond its role on lymphatic endothelial cells (LECs),14 it is currently unclear whether the cardioprotective actions of VEGFC treatment following MI are due to promotion of VEGFC-dependent lymphangiogenesis.